CommercialAdministrativeLow impact
Radicava (edaravone)
Blue Cross & Blue Shield of Mississippi·MS · Neurology·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi updated their Radicava (edaravone) policy for ALS treatment with minor clarifications to description and policy language, but coverage criteria remain unchanged. The policy still requires prior authorization for both initial approval and 6-month renewals.
Action Required
No immediate action required. This is a clarification update with no changes to coverage criteria or prior authorization requirements. Continue following existing prior authorization workflow for Radicava (edaravone) using HCPCS code J1301.